OPIANT

Serial Number 97461127
Registration 7283331
700

Registration Progress

Application Filed
Jun 16, 2022
Under Examination
Approved for Publication
Nov 7, 2023
Published for Opposition
Nov 7, 2023
Registered
Jan 23, 2024

Trademark Image

OPIANT

Basic Information

Serial Number
97461127
Registration Number
7283331
Filing Date
June 16, 2022
Registration Date
January 23, 2024
Published for Opposition
November 7, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 23, 2024
Registration
Registered
Classes
042

Rights Holder

Opiant Pharmaceuticals, Inc.

03
Address
233 Wilshire Blvd., Suite 400
Santa Monica, CA 90401

Ownership History

Opiant Pharmaceuticals, Inc.

Original Applicant
03
Santa Monica, CA

Opiant Pharmaceuticals, Inc.

Owner at Publication
03
Santa Monica, CA

Opiant Pharmaceuticals, Inc.

Original Registrant
03
Santa Monica, CA

Legal Representation

Attorney
Joseph A. Mahoney

USPTO Deadlines

Next Deadline
1494 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240123)
Due Date
January 23, 2030
Grace Period Ends
July 23, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

15 events
Date Code Type Description Documents
Jan 23, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 23, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 23, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jan 4, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 7, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 7, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 18, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 2, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Apr 3, 2023 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Apr 3, 2023 GNSL F LETTER OF SUSPENSION E-MAILED Loading...
Apr 3, 2023 CNSL R SUSPENSION LETTER WRITTEN Loading...
Mar 29, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 1, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jun 30, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 20, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Pharmaceutical drug development services; pharmaceutical research services; development of pharmaceutical preparations and medicines for the treatment of neurological and psychiatric diseases and disorders relating to drug and chemical addictions, drug overdoses and eating disorders
First Use Anywhere: Jan 1, 2019
First Use in Commerce: Jan 1, 2019

Additional Information

Design Mark
The mark consists of the word "OPIANT" with three balloon designs set slightly to the left and above the "O" in "OPIANT".

Classification

International Classes
042